EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseStudienprotokollOpen Access · CC BY 4.0

Anti-inflammatory effects of metformin in gestational diabetes: Systematic review and meta-analysis of randomized trials and preclinical animal pregnancy models study protocol

Israel Ogwuche Ogra, Aghogho Oyibo, Fabrice Banadzem Kernyuy, Ayomide Oluwaseun Adereti, Babalola Ooreofe Feranmi iD, Kayode Olayinka Afolabi iD, Glory Chinuru Musa, Vivian Onyinye Ojiakor iD, Umar-Farouq A Mahe, Oluwatoyin Osinimega Ojo, Mahmoud Werfalli, Samuel Ohiomokhare und 3 weitere

PLOS One · 12.11.2026 · 21 (11) · e0361047

DOI: 10.1371/journal.pone.0361047 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift PLOS One, online erschienen am 12.11.2026. Verfasst von Israel Ogwuche Ogra und 14 weiteren Autor:innen. Beteiligte Einrichtung: UNESCO International Centre for Biotechnology, Nsukka, Enugu State, Nigeria. Hauptthemen laut MEDLINE: Metformin, Diabetes, Gestational, Anti-Inflammatory Agents, Hypoglycemic Agents. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Gestational diabetes mellitus (GDM) is a significant complication that can occur during pregnancy. It is characterized by glucose intolerance that first arises during pregnancy and is associated with insulin resistance, which is linked to elevated inflammatory markers. Metformin has emerged as a promising treatment option for GDM, with growing evidence supporting its anti-inflammatory effects. These effects are thought to be mediated by activation of AMP-activated protein kinase (AMPK) and inhibition of NF-κB signaling. This systematic review aims to assess the anti-inflammatory effects of metformin in GDM, considering both clinical and preclinical studies.

Methods

A systematic review of all randomized controlled trials and controlled in vivo experiments for animals published until 2026 will be carried out. A comprehensive search of all published articles indexed in PubMed/MEDLINE, the Cochrane Library, Scopus, CINAHL (EBSCOhost), Embase, and Web of Science will be performed. Studies will be screened for eligibility by title, abstract, and full text in duplicate by two independent reviewers. For data where meta-analysis is not possible, a narrative analysis will be conducted using themes derived from the data. For data that allow meta-analysis, a random-effects meta-analysis will be conducted. This systematic review will be reported in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA).

Discussion

The study will utilize meta-analysis to establish the anti-inflammatory effects of metformin in GDM, potentially influencing clinical practice and guidelines. Additionally, validating metformin’s anti-inflammatory effects has important implications beyond immediate management of GDM, extending to long-term adverse outcomes for both the mother and the offspring.

Systematic review registration

PROSPERO CRD420261337881

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MetforminDiabetes, GestationalAnti-Inflammatory AgentsHypoglycemic AgentsFemalePregnancyAnimalsSystematic Reviews as TopicHumansMeta-Analysis as TopicRandomized Controlled Trials as TopicDisease Models, Animal

Substanzen

MetforminAnti-Inflammatory AgentsHypoglycemic Agents

Autor:innen und Institutionen

  • UNESCO International Centre for Biotechnology, Nsukka, Enugu State, Nigeria.
  • Biological Institute, Tomsk State University, Tomsk, Russia.
  • Department of Biochemistry, Christland University, Abeokuta, Nigeria.
  • Drosophila Research and Training Centre, Ibadan, Nigeria.
  • Department of Biochemistry, Covenant University, Ota, Ogun State, Nigeria.
  • Faculty of Veterinary Medicine, University of Nigeria, Nsukka, Nigeria.

ORCID-Profile: Babalola Ooreofe Feranmi, Kayode Olayinka Afolabi, Vivian Onyinye Ojiakor, Kodjovi Sossou, Olayinka Sunday Okoh

Zitieren

APA

Ogra, I. O., Oyibo, A., Kernyuy, F. B., Adereti, A. O., Feranmi, B. O., Afolabi, K. O., Musa, G. C., Ojiakor, V. O., Mahe, U. A., Ojo, O. O., Werfalli, M., Ohiomokhare, S., Sossou, K., Okoh, O. S., & Musa, E. (2026). Anti-inflammatory effects of metformin in gestational diabetes: Systematic review and meta-analysis of randomized trials and preclinical animal pregnancy models study protocol. PLOS One, 21(11), e0361047. https://doi.org/10.1371/journal.pone.0361047

Vancouver

Ogra IO, Oyibo A, Kernyuy FB, Adereti AO, Feranmi BO, Afolabi KO, et al. Anti-inflammatory effects of metformin in gestational diabetes: Systematic review and meta-analysis of randomized trials and preclinical animal pregnancy models study protocol. PLOS One. 2026;21(11):e0361047. doi:10.1371/journal.pone.0361047

BibTeX
@article{Ogra2026,
  author = {Ogra, Israel Ogwuche and Oyibo, Aghogho and Kernyuy, Fabrice Banadzem and Adereti, Ayomide Oluwaseun and Feranmi, Babalola Ooreofe and Afolabi, Kayode Olayinka and Musa, Glory Chinuru and Ojiakor, Vivian Onyinye and Mahe, Umar-Farouq A and Ojo, Oluwatoyin Osinimega and Werfalli, Mahmoud and Ohiomokhare, Samuel and Sossou, Kodjovi and Okoh, Olayinka Sunday and Musa, Ezekiel},
  title = {Anti-inflammatory effects of metformin in gestational diabetes: Systematic review and meta-analysis of randomized trials and preclinical animal pregnancy models study protocol},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {11},
  pages = {e0361047},
  doi = {10.1371/journal.pone.0361047}
}
Kostenlos starten →